160 related articles for article (PubMed ID: 15197772)
1. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.
Coon SW; Savera AT; Zarbo RJ; Benninger MS; Chase GA; Rybicki BA; Van Dyke DL
Int J Cancer; 2004 Aug; 111(2):206-12. PubMed ID: 15197772
[TBL] [Abstract][Full Text] [Related]
2. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
3. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
4. Association of deletion in the chromosomal 8p21.3-23 region with the development of invasive head & neck squamous cell carcinoma in Indian patients.
Bhattacharya N; Tripathi A; Dasgupta S; Sabbir MG; Roy A; Sengupta A; Roy B; Roychowdhury S; Panda CK
Indian J Med Res; 2003 Aug; 118():77-85. PubMed ID: 14680203
[TBL] [Abstract][Full Text] [Related]
5. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
8. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D
Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798
[TBL] [Abstract][Full Text] [Related]
11. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder.
Abdel Wahab AH; Abo-Zeid HI; El-Husseini MI; Ismail M; El-Khor AM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):260-9. PubMed ID: 17102820
[TBL] [Abstract][Full Text] [Related]
12. Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.
Ye H; Pungpravat N; Huang BL; Muzio LL; Mariggiò MA; Chen Z; Wong DT; Zhou X
Cancer Genet Cytogenet; 2007 Jul; 176(2):100-6. PubMed ID: 17656251
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
[TBL] [Abstract][Full Text] [Related]
14. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D
Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
[TBL] [Abstract][Full Text] [Related]
16. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma.
Matsuura K; Shiga K; Yokoyama J; Saijo S; Miyagi T; Takasaka T
Anticancer Res; 1998; 18(1A):453-8. PubMed ID: 9568119
[TBL] [Abstract][Full Text] [Related]
18. 9p21 deletion correlates with recurrence in head and neck cancer.
Lydiatt WM; Davidson BJ; Schantz SP; Caruana S; Chaganti RS
Head Neck; 1998 Mar; 20(2):113-8. PubMed ID: 9484941
[TBL] [Abstract][Full Text] [Related]
19. [Loss of heterozygosity of 3p21 and 9p21 in head and neck squamous cell carcinomas and its prognostic implication].
Matsuura K; Shiga K; Yokoyama J; Tateda M; Nakano H; Saijo S; Takasaka T
Nihon Jibiinkoka Gakkai Kaiho; 1999 May; 102(5):613-21. PubMed ID: 10388315
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]